DMPA-SC resources and references

By Reproductive Health

Mounting evidence and experience shows that integrating DMPA-SC across multiple delivery channels in a country’s family planning program can help expand contraceptive access and options.

By collaborating with ministries of health and partners, PATH has generated a rich repository of experience and evidence on the injectable contraceptive, subcutaneous DMPA (DMPA-SC, brand name Sayana® Press). The following resources can support countries, implementing partners, and donors interested in introducing or scaling up this new contraceptive option in their family planning programs.

For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

Key resources

*DMPA-SC: Subcutaneous depot medroxyprogesterone acetate.
Sayana Press is a registered trademark of Pfizer Inc. Uniject is a trademark of BD.

Read More

The power to prevent pregnancy in women’s hands: DMPA-SC injectable contraception
Reproductive Health
Sexual & Reproductive Health